Balaxi Pharmaceuticals Limited (BALAXI.NS)

INR 64.61

(-2.25%)

Revenue Summary of Balaxi Pharmaceuticals Limited

Balaxi Pharmaceuticals Limited's latest annual revenue in 2023 was 2.38 Billion INR , down -29.07% from previous year.
Balaxi Pharmaceuticals Limited's latest quarterly revenue in 2024 Q1 was 637.73 Million INR , up 9.87% from previous quarter.
Balaxi Pharmaceuticals Limited reported a annual revenue of 3.36 Billion INR in annual revenue 2022, up 20.42% from previous year.
Balaxi Pharmaceuticals Limited reported a annual revenue of 2.79 Billion INR in annual revenue 2021, up 20.77% from previous year.
Balaxi Pharmaceuticals Limited reported a quarterly revenue of 580.47 Million INR for 2023 Q4, down -4.5% from previous quarter.
Balaxi Pharmaceuticals Limited reported a quarterly revenue of 607.85 Million INR for 2023 Q3, up 11.08% from previous quarter.

Annual Revenue Chart of Balaxi Pharmaceuticals Limited (2023 - 2012)

Historical Annual Revenue of Balaxi Pharmaceuticals Limited (2023 - 2012)

Year	Revenue	Revenue Growth
2023	2.38 Billion INR	-29.07%
2022	3.36 Billion INR	20.42%
2021	2.79 Billion INR	20.77%
2020	2.31 Billion INR	406.95%
2019	456.32 Million INR	235.65%
2018	135.95 Million INR	27190920.0%
2017	-500.00 INR	99.99%
2016	-6.14 Million INR	-1393.29%
2015	475.11 Thousand INR	-61.61%
2014	1.23 Million INR	-35.86%
2013	1.92 Million INR	123.97%
2012	861.33 Thousand INR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	637.73 Million INR	9.87%
2023 Q4	580.47 Million INR	-4.5%
2023 Q3	607.85 Million INR	11.08%
2023 Q1	659.55 Million INR	-18.25%
2023 FY	2.38 Billion INR	-29.07%
2023 Q2	547.2 Million INR	-17.03%
2022 Q1	806.81 Million INR	-9.45%
2022 FY	3.36 Billion INR	20.42%
2022 Q4	806.81 Million INR	-6.81%
2022 Q3	865.81 Million INR	31.27%
2022 Q2	659.55 Million INR	-18.25%
2021 Q3	617.23 Million INR	-12.11%
2021 Q2	702.29 Million INR	20.39%
2021 Q4	890.99 Million INR	44.35%
2021 FY	2.79 Billion INR	20.77%
2021 Q1	583.35 Million INR	10.16%
2020 Q3	659.9 Million INR	9.38%
2020 FY	2.31 Billion INR	406.95%
2020 Q2	603.29 Million INR	15.89%
2020 Q4	529.53 Million INR	-19.76%
2020 Q1	520.58 Million INR	344.63%
2019 Q4	117.08 Million INR	-10.92%
2019 Q2	125.52 Million INR	52.54%
2019 Q1	82.28 Million INR	37.96%
2019 FY	456.32 Million INR	235.65%
2019 Q3	131.42 Million INR	4.71%
2018 Q1	- INR	0.0%
2018 FY	135.95 Million INR	27190920.0%
2018 Q4	59.64 Million INR	-3.94%
2018 Q3	62.08 Million INR	336.58%
2018 Q2	14.22 Million INR	0.0%
2017 Q2	- INR	0.0%
2017 FY	-500.00 INR	99.99%
2017 Q4	- INR	0.0%
2017 Q3	- INR	0.0%
2017 Q1	- INR	100.0%
2016 Q1	18.75 Thousand INR	-65.27%
2016 FY	-6.14 Million INR	-1393.29%
2016 Q4	-6.16 Million INR	0.0%
2016 Q3	- INR	0.0%
2016 Q2	- INR	-100.0%
2015 Q3	227 Thousand INR	1058.16%
2015 Q2	19.6 Thousand INR	-88.76%
2015 Q1	174.33 Thousand INR	-55.47%
2015 FY	475.11 Thousand INR	-61.61%
2015 Q4	53.98 Thousand INR	-76.22%
2014 Q3	766 Thousand INR	0.0%
2014 FY	1.23 Million INR	-35.86%
2014 Q4	391.44 Thousand INR	-48.9%
2013 FY	1.92 Million INR	123.97%
2012 FY	861.33 Thousand INR	0.0%

Peer Revenue Comparison of Balaxi Pharmaceuticals Limited

Name	Revenue	Revenue Difference